Acadia Pharmaceuticals | ACAD - Денежные средства и эквиваленты

Биржевая цена
21.85
Изменение за день
-0.60 -2.67%
Ежемесячно
-1.58%
Ежегодный
46.55%
Q2 прогноз
21.49




Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Biogen USD 3.38B 374.2M 2026-03
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Cara Therapeutics USD 21.42M 770K 2025-09
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Cytokinetics USD 122.52M 102.95M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 5.28B 1.99B 2026-03
Incyte USD 4.02B 435.22M 2026-03
J&J USD 21.69B 1.98B 2026-03
Moderna USD 1.91B 687M 2026-03
Neurocrine Biosciences USD 713M 372.8M 2025-12
Pfizer USD 1.34B 295M 2025-09
Prothena USD 307.53M 23.31M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12